| Cat. No. |
Product Name / Activity |
| 6774 |
16673-34-0 NLRP3i |
| NLRP3 inflammasome inhibitor |
| 6827 |
Artesunate |
| Suppresses ROS-induced activation of the NLRP3 inflammasome; antimalarial |
| 1744 |
Bay 11-7821 |
| Inhibits NLRP3 inflammasome activation; binds and inhibits gasdermin D |
| 1364 |
Colchicine |
| Suppresses NLRP3 inflammasome; anti-inflammatory; also promotes microtubule depolymerization |
| 5479 |
CRID3 sodium salt |
| Potent NLRP3 inflammasome inhibitor |
| 6436 |
CY 09 |
| NLRP3 inhibitor; active in vivo |
| 6902 |
Dapansutrile |
| NLRP3 inflammasome inhibitor; disrupts inflammasome formation |
| 3807 |
Disulfiram |
| Pyroptosis inhibitor; binds gasdermin D and inhibits pore formation |
| 0927 |
Fluoxetine hydrochloride |
| Inhibits assembly and activation of NLRP3-ASC inflammasomes; also 5-HT reuptake inhibitor |
| 6341 |
INF 39 |
| Irreversible NLRP3 inhibitor |
| 6172 |
INF 4E |
| Caspase-1 and NLRP3 inflammasome inhibitor |
| 6722 |
NBC 19 |
| Potent NLRP3 inflammasome inhibitor |
| 6925 |
NBC 6 |
| NLRP3 inflammasome inhibitor |
| 7808 |
NDT 30805 |
| Potent NLRP3 inflammasome inhibitor |
| 5025 |
Necrosulfonamide |
| Pyroptosis inhibitor; binds gasdermin D and inhibits pore formation |
| 2163 |
Z-VAD-FMK |
| Irreversible caspase inhibitor; cell-permeable |